LIGHT/TNFSR14 Can Regulate Hepatic Lipase Expression by Hepatocytes Independent of T Cells and Kupffer Cells

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Chellan, Bijoy ^a   Koroleva, Ekaterina P ^b   Sontag, Timothy J ^a   Tumanov, Alexei V ^b   Fu, Yang Xin ^a   Getz, Godfrey S ^a   Reardon, Catherine A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b TRUDEAU INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; HERPESVIRUS ENTRY MEDIATOR LIGAND; LIVER TRIACYLGLYCEROL LIPASE; LYMPHOTOXIN BETA RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPLETION; DOWN REGULATION; KUPFFER CELL; LIVER CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTES; KUPFFER CELLS; LIPASE; LYMPHOTOXIN BETA RECEPTOR; MICE; MICE, KNOCKOUT; ORGAN SPECIFICITY; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14;

MUS;

EID: 84872793355     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054719     Document Type: Article

References (49)

1. Ware CF, (2005) Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol 23: 787-819.
2. Xu Y, Tamada K, Chen L, (2007) LIGHT-related molecular network in the regulation of innate and adoptive immunity. Immunol Res 37: 17-32.
3. Anand S, Wang P, Yoshimura K, Choi IH, Hilliard A, et al. (2006) Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitis. J Clin Invest 116: 1045-1051.
4. Lee WH, Kim SH, Lee Y, Lee BB, Kwon B, et al. (2001) Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler Thromb Vasc Biol 21: 2004-2010.
5. Scholz H, Sandberg W, Damås JK, Smith C, Anreassen AK, et al. (2005) Enhanced plasma levels of LIGHT in unstable angina: possible pathogenic role in foam cell formation and thrombosis. Circulation 112: 2121-2129.
6. Dahl CP, Gullestad L, Fevang B, Holm AM, Landrø L, et al. (2008) Increased expression of LIGHT/TNFS14 and its receptors in experimental and clinical heart failure. Eur J Heart Fail 10: 352-359.
7. Wang J, Lo JC, Foster A, Yu P, Chen HM, et al. (2001) The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J Clin Invest 108: 1741-1742.
8. Lo JC, Wang Y, Tumanov AV, Bamji M, Yao Z, et al. (2007) Lymphotoxin β receptor-dependent control of lipid homeostasis. Science 316: 285-288.
9. Perret B, Mabile L, Martinez L, Tercé F, Barbaras R, et al. (2002) Hepatic lipase: structure/function relationship, synthesis, and regulation. J Lipid Res 43: 1163-1169.
10. Santamarina-Fojo S, González-Navarro H, Freeman L, Wagner E, Nong Z, (2004) Hepatic lipase, lipoprotein, metabolism, and atherosclerosis. Arterioscler Thromb Vasc Biol 24: 1750-1754.
11. Zambon A, Deeb SS, Pauletto P, Crepaldi G, Brunzell JD, (2003) Hepatic lipase: a marker for cardiovascular disease risk and response to therapy. Curr Opin Lipidol 14: 179-180.
12. Annema W, Tietge UJF, (2011) Role of hepatic lipase and endothelial lipase in high-density lipoprotein-mediated reverse cholesterol transport. Curr Atheroscler Rep 13: 257-265.
13. Jansen H, (2004) Hepatic lipase: friend or foe and under what circumstances? Curr Atheroscler Rep 6: 343-347.
14. Crispe IN, (2009) Liver as a lymphoid organ. Annu Rev Immunol 27: 147-163.
15. Anders RA, Subudhi SK, Wang J, Pfeffer K, Fu YX, (2005) Contribution of the lymphotoxin β receptor to liver regeneration. J Immunol 175: 1295-1300.
16. Wang Y, Subudhi SK, Anders RA, Lo J, Sun Y, et al. (2005) The role of herpes virus entry mediator as a negative regulator of T cell-mediated responses. J Clin Invest 115: 711-717.
17. Reardon CA, Blachowicz L, Lukens J, Nissenbaum M, Getz GS, (2003) Genetic background selectively influences innominate artery atherosclerosis: Immune system deficiency as a probe. Arterioscler Thromb Vasc Biol. 23: 1449-1454.
18. Wang Y, Koroleva EP, Kruglov AA, Kuprach DV, Sergei A, et al. (2010) Lymphotoxin β receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection. Immunity 32: 403-413.
19. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, et al. (1999) Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β cell-specific gene knock-outs using Cre recombinase. J Biol Chem 274: 305-315.
20. Yu P, Lee Y, Wang Y, Liu X, Gajewski TF, et al. (2011) Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases. J Immunol 179: 1960-1968.
21. Sacci JB, (2002) Hepatocyte perfusion, isolation, and culture. Meth Mol Med 72: 503-505.
22. Lee WY, Moriarty TJ, Wong CHY, Zhou H, Strieter RM, et al. (2010) An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nat Immunol 11: 295-302.
23. Cohen JI, Nagy LE, (2011) Pathogenesis of alcoholic liver disease: interactions between parenchymal and non-parenchymal cells. J Dig Dis 12: 3-9.
24. Perry BC, Soltys D, Toledo AH, Toledo-Pereyra LH, (2011) Tumor necrosis factor-α in liver ischemia/reperfusion injury. J Invest Surg 24: 178-188.
25. Gregory SH, Wing EJ, Danowski KL, van Rooijen N, Dyer KF, et al. (1998) IL-6 produced by Kupffer cells induces STAT protein activation in hepatocytes early during the course of systemic listerial infections. J Immunol 16: 6056-6061.
26. Bogers WM, Stad RK, Janssen DJ, van Rooijen N, van Es LA, et al. (1991) Kupffer cell depletion in vivo results in clearance of large-sized IgA aggregates in rats by liver endothelial cells. Clin Exp Immunol 85: 128-136.
27. van Rooijen N, Sanders A, (1996) Kupffer cell depletion by liposome-delivered drugs: comparative activity of intracellular clodronate, proamidine, and ethylenediaminetetraacetic acid. Hepatology 23: 1239-1243.
28. Li W, Rosenzweigh A, Huber BT, (2003) Differential T-cell activation by B7-1 expression. Immunology 109: 336-342.
29. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, et al. (1992) RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-677.
30. Feingold KR, Memon RA, Moser AH, Shigenaga JK, Grunfeld C, (1999) Endotoxin and interleukin-1 decrease hepatic lipase mRNA levels. Atherosclerosis 142: 379-387.
31. Stienstra R, Saudale F, Duval C, Keshtkar S, Groener JEM, et al. (2010) Kupffer cells promote hepatic steatosis via interleukin-1β-dependent suppression of peroxisome proliferator-activated receptor α activity. Hepatology 51: 511-522.
32. Cartmel T, Southgate T, Rees GS, Castro MJ, Lowenstein PR, et al. (1999) Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain. J Neurosci 19: 1517-1523.
33. Allan SM, Tyrrell PJ, Rothwell NJ, (2005) Interleukin-1 and neuronal injury. Nat Rev Immunol. 5: 629-640.
34. Wimmer N, Huber B, Barabas N, Röhrl J, Pfeffer K, et al. (2012) Lymphotoxin β receptor activation on macrophages induces cross-tolerance to TLR4 and TLR9 ligands. J Immunol 188: 3426-3433.
35. Lee CM, Knight B, Yeoh GC, Ramm GA, Olynky JK, (2005) Lymphotoxin-β production following bile duct ligation: possible role for Kupffer cells. J Gastroenterol Hepatol 20: 1762-1768.
36. Murphy KM, Nelson CA, Šedý JR, (2006) Balancing co-stimulation and inhibition of BTLA and HVEM. Nat Rev Immunol 6: 671-681.
37. Fütterer A, Mink K, Luz A, Kosco-Vilbois MH, Pfeffer K, (1998) The lymphotoxin β receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 9: 59-70.
38. Magilavy DB, Zhan R, Black DD, (1993) Modulation of murine hepatic lipase activity by exogenous and endogenous Kupffer-cell activation. Biochem J 292: 249-252.
39. Kawakami M, Murase T, Itakura H, Yamada N, Ohsawa N, et al. (1986) Lipid metabolism in endotoxic rats: decrease in hepatic triglyceride lipase activity. Microbiol Immunol 30: 849-854.
40. Meraïhi Z, Lutz O, Scheftel JM, Frey A, Ferezou J, et al. (1991) Decreased lipolytic activity in tissues curing infectious and inflammatory stress. Nutrition 7: 93-97.
41. Bertolino P, Trescol-Biémont MC, Rabourdin-Combe C, (1998) Hepatocytes induce functional activation of naïve CD8+ T lymphocytes but fail to promote survival. Eur J Immunol 28: 221-236.
42. Bertolino P, Trescol-Biémont MC, Thomas J, Fazekas de St Groth B, Pihlgren M, et al. (1999) Death by neglect as a deletional mechanism of peripheral tolerance. Int Immunol 11: 1225-1238.
43. Schönrich G, Momburg F, Malissen M, Schmitt-Verhulst AM, Malissen B, et al. (1992) Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self-antigen. Int Immunol 4: 581-590.
44. Morahan G, Brennan FE, Bhathal PS, Allison J, Cox KO, et al. (1989) Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter. Proc Natl Acad Sci USA 86: 3782-3786.
45. Otterdal K, Andreassen AK, Yndestad A, Oie E, Sandberg WJ, et al. (2008) Raised LIGHT levels in pulmonary arterial hypertension: potential role in thrombus formation. Am J Respir Crit Care Med 177: 202-207.
46. Rufibach LE, Duncan SA, Battle M, Deeb SS, (2006) Transcriptional regulation of human hepatic lipase (LIPC) gene promoter. J Lipid Res 47: 1463-1477.
47. Remouchamps C, Boutaffala L, Ganeff C, Dejardin E, (2011) Biology and signal transduction pathways of the lymphotoxin-αβ/LTβR system. Cyto Growth Factor Rev 22: 301-310.
48. Jin W, Sun GS, Marchadier D, Octtavian E, Glick JM, et al. (2003) Endothelial cells secrete triglyceride lipase and phospholipase activities in response to cytokines as a result of endothelial lipase. Circ Res 92: 644-650.
49. Brunzell JD, Zambon A, Deeb SS, (2011) The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype. Biochim Biophys Acta 1821: 365-372.